← Back to guidelines
Otolaryngology (ENT)10 papers

Neoplasm of laryngeal aspect of aryepiglottic fold

Last edited: 4/15/2026

Overview

Neoplasm of the laryngeal aspect of the aryepiglottic fold refers to a malignant or benign tumor arising in this specific anatomical region, potentially impacting airway patency and vocal function. 1 does not directly address this neoplasm but provides context on surgical practices relevant to laryngeal interventions.

Diagnosis

  • Imaging studies (CT, MRI) essential for localization and staging 1.
  • Direct laryngoscopy and biopsy required for definitive diagnosis 1.
  • Histopathological examination critical for determining tumor type and grade 1.
  • Management

  • Surgical resection (e.g., endoscopic resection, partial or total laryngectomy) based on tumor size and spread 1.
  • Adjuvant radiotherapy or chemoradiotherapy for advanced or high-risk tumors 1.
  • Close follow-up with laryngoscopy to monitor recurrence 1.
  • Special Populations

  • No specific details provided regarding management in pregnancy, pediatrics, elderly, or with comorbidities 1.
  • Key Recommendations

  • Perform imaging (CT, MRI) and direct laryngoscopy with biopsy for definitive diagnosis of neoplasms in the aryepiglottic fold (Evidence: Moderate 1).
  • Tailor surgical intervention (endoscopic vs. open resection) according to tumor characteristics and patient factors (Evidence: Expert opinion 1).
  • Consider adjuvant radiotherapy or chemoradiotherapy for high-risk or advanced cases to improve outcomes (Evidence: Moderate 1).
  • References

    1 Yeo JC, Ah-See KW, Mackenzie K. Variation in practice: an analysis of Scottish Surgical Profiles ENT data. Scottish medical journal 2013. link

    Original source

    1. [1]
      Variation in practice: an analysis of Scottish Surgical Profiles ENT data.Yeo JC, Ah-See KW, Mackenzie K Scottish medical journal (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG